We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
+13.21%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
AUM
$1.07B
AUM Growth
+$51.2M
Cap. Flow
-$43M
Cap. Flow %
-4.01%
Top 10 Hldgs %
8.18%
Holding
1,747
New
747
Increased
219
Reduced
207
Closed
574

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$12.1M
2
AAPL icon
Apple
AAPL
+$8.41M
3
MSI icon
Motorola Solutions
MSI
+$7.68M
4
JD icon
JD.com
JD
+$7.3M
5
ITW icon
Illinois Tool Works
ITW
+$6.58M

Top Sells

Rank Stock Value
1
BX icon
Blackstone
BX
+$11.4M
2
KVUE icon
Kenvue
KVUE
+$8.1M
3
RTX icon
RTX Corp
RTX
+$7.61M
4
CSCO icon
Cisco
CSCO
+$6.72M
5
ADBE icon
Adobe
ADBE
+$6.58M

Sector Composition

Rank Sector Weight
1 Technology 16.62%
2 Financials 15.83%
3 Consumer Discretionary 13.61%
4 Healthcare 10.98%
5 Industrials 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TGLS icon
751
Tecnoglass
TGLS
$2.09B
$361K 0.03%
+7,887
New +$285K
ITRI icon
752
Itron
ITRI
$4.75B
$360K 0.03%
4,774
-14,430
-75% -$938K
AAN
753
DELISTED
The Aaron's Company Inc
AAN
$360K 0.03%
33,046
+10,464
+46% +$97.1K
SITM icon
754
SiTime
SITM
$14.7B
$359K 0.03%
+2,943
New +$333K
MDGL icon
755
Madrigal Pharmaceuticals
MDGL
$12.4B
$359K 0.03%
+1,551
New +$271K
VET icon
756
Vermilion Energy
VET
$1.59B
$359K 0.03%
29,731
-22,775
-43% -$301K
ALNY icon
757
Alnylam Pharmaceuticals
ALNY
$38.5B
$355K 0.03%
+1,855
New +$316K
CUK
758
DELISTED
Carnival PLC
CUK
$355K 0.03%
21,027
-917
-4% -$12K
PWP icon
759
Perella Weinberg Partners
PWP
$1.18B
$354K 0.03%
+28,921
New +$315K
RWAY icon
760
Runway Growth Finance
RWAY
$234M
$354K 0.03%
+28,016
New +$350K
SPXC icon
761
SPX Corp
SPXC
$10.2B
$353K 0.03%
3,493
-2,044
-37% -$177K
CBAY
762
DELISTED
Cymabay Therapeutics
CBAY
$353K 0.03%
+14,924
New +$266K
LOCO icon
763
El Pollo Loco
LOCO
$497M
$353K 0.03%
+39,966
New +$344K
PDS
764
Precision Drilling
PDS
$1.01B
$351K 0.03%
6,467
+827
+15% +$47.8K
XYLD icon
765
Global X S&P 500 Covered Call ETF
XYLD
$3.21B
$350K 0.03%
+8,885
New +$346K
SBGI icon
766
Sinclair Inc
SBGI
$1.02B
$344K 0.03%
+26,419
New +$324K
TDS icon
767
Telephone and Data Systems
TDS
$3.87B
$342K 0.03%
+18,634
New +$344K
RWT
768
Redwood Trust
RWT
$585M
$342K 0.03%
+46,109
New +$323K
EDR
769
DELISTED
Endeavor Group Holdings, Inc.
EDR
$340K 0.03%
14,337
-24,283
-63% -$547K
CASH icon
770
Pathward Financial
CASH
$1.87B
$340K 0.03%
6,418
-4,057
-39% -$199K
CVSA
771
Covista Inc
CVSA
$4.3B
$339K 0.03%
5,758
-2,115
-27% -$113K
GPRK icon
772
GeoPark
GPRK
$601M
$339K 0.03%
+39,597
New +$374K
QDEL icon
773
QuidelOrtho
QDEL
$1.14B
$338K 0.03%
+4,588
New +$310K
FSLY icon
774
Fastly Inc
FSLY
$3.26B
$338K 0.03%
+18,993
New +$320K
PRI icon
775
Primerica
PRI
$10B
$338K 0.03%
1,642
-331
-17% -$67.6K

Similar funds

Y-Intercept (HK)'s Q4 2023 Portfolio in Review

As of Q4 2023, Y-Intercept (HK) held 1,747 positions worth $1.07B, up 5% from $1.02B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

Y-Intercept (HK) withdrew a net $43M in Q4 2023, closing 574 positions and reducing 207 holdings. Its most notable exit was Blackstone, an estimated $11.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Y-Intercept (HK) opened a new position in Merck worth $12.7M.

  • Y-Intercept (HK)'s largest Q4 2023 buy was Merck: 116,714 shares worth $12.7M.
  • Y-Intercept (HK) added most to Apple in Q4 2023, an estimated $8.41M increase.
  • Y-Intercept (HK)'s biggest Q4 2023 reduction was Kenvue, cutting an estimated $8.1M.
  • Y-Intercept (HK) fully exited Blackstone in Q4 2023, selling an estimated $11.4M.
  • Y-Intercept (HK)'s ten largest holdings make up 8.2% of its $1.07B portfolio in Q4 2023.
  • Y-Intercept (HK) opened 747 new positions and closed 574 in Q4 2023.
  • Y-Intercept (HK)'s portfolio value rose 5% quarter-over-quarter to $1.07B.

Based on Y-Intercept (HK)'s 13F filing for Q4 2023, filed 13 Feb 2024.